Centro Riproduzione e Andrologia

Centro Riproduzione e Andrologia (CREA) is a specialized medical center located in Taranto, Italy, dedicated to reproductive medicine and andrology. Founded in 1990, the center provides a comprehensive range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and intrauterine insemination (IUI). CREA is recognized for its expertise in male fertility, offering advanced diagnostics and surgical sperm retrieval procedures such as TESE and TESA. In 2018, the center was acquired by NMC Health and later became part of the Eugin Group, which was subsequently acquired by Fresenius Helios in 2021. The clinic serves as a key regional hub for fertility preservation and the treatment of complex reproductive disorders in Southern Italy.